Upbeat economic data from China, including industrial production rising 10.3% and retail sales up 13.3%, keep futures flat in the US ahead of the week’s trading. Shire acquires Viropharma for $4.2 billion to increase their rare disease portfolio. Annual cost synergies of $150 million are expected by 2015. Transocean increases their dividend to $3 per share after releasing earnings last week. The company will also create an MLP and set a cost savings target of $500 million by 2015. TheStreet’s Joe Deaux and Nicole Urken report in New York.
Subscribe to TheStreetTV on YouTube:
For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:
source
